These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6735021

  • 41. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
    Aghazadeh-Habashi A, Sattari S, Pasutto F, Jamali F.
    J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
    [Abstract] [Full Text] [Related]

  • 42. Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.
    Ranney RE, Dean RR, Karim A, Radzialowski FM.
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):162-88. PubMed ID: 4104224
    [No Abstract] [Full Text] [Related]

  • 43. Pharmacokinetic investigations of Craviten. II. Dose-dependent elimination kinetics in rats following rapid intravenous injection.
    Danek A, Witek J.
    Pol J Pharmacol Pharm; 1980 May; 32(6):933-9. PubMed ID: 7243690
    [Abstract] [Full Text] [Related]

  • 44. Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillators.
    Schwartzman D, Harvey MN, Hoyt RH, Koehler JL, Ujhelyi MR, Euler DE.
    Europace; 2006 Mar; 8(3):211-5. PubMed ID: 16627442
    [Abstract] [Full Text] [Related]

  • 45. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

  • 46. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F, Palmieri M, del Corso P, Lombardi G, Bracchetti D.
    Arzneimittelforschung; 1982 Oct; 32(5):547-50. PubMed ID: 7201833
    [Abstract] [Full Text] [Related]

  • 47. [Electrophysiologic characterization of propafenone in man].
    Masini G, Dianda R, Masini M.
    G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
    [Abstract] [Full Text] [Related]

  • 48. Identification of a metabolite of propafenone in human urine by means of high-performance liquid chromatography and gas chromatography--mass spectrometry.
    Marchesini B, Boschi S.
    J Chromatogr; 1983 Nov 11; 278(1):173-8. PubMed ID: 6662877
    [No Abstract] [Full Text] [Related]

  • 49. The pharmacokinetics of Norpace.
    Karim A.
    Angiology; 1975 Jan 11; 26(1 Pt 2):85-98. PubMed ID: 1090217
    [No Abstract] [Full Text] [Related]

  • 50. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W, Barth H, Becker R, Frankus E, Schmidt-Böthelt E.
    Arzneimittelforschung; 1998 May 11; 48(5):436-45. PubMed ID: 9638309
    [Abstract] [Full Text] [Related]

  • 51. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
    Trenk D, Wagner F, Sachs W, Jähnchen E.
    Eur J Clin Pharmacol; 1989 May 11; 37(3):313-6. PubMed ID: 2612546
    [Abstract] [Full Text] [Related]

  • 52. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part I.
    Singh BN, Cho YW, Kuemmerle HP.
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr 11; 19(4):139-51. PubMed ID: 7263102
    [No Abstract] [Full Text] [Related]

  • 53. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L, Venuti M, Orlando R, Lirussi F, Nassuato G, Benvenuti C.
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct 11; 20(10):482-7. PubMed ID: 7141756
    [Abstract] [Full Text] [Related]

  • 54. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V, Puozzo C.
    Expert Opin Drug Saf; 2005 Sep 11; 4(5):915-28. PubMed ID: 16111453
    [Abstract] [Full Text] [Related]

  • 55. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S, Sweeney RW, Bélanger M.
    Am J Vet Res; 1996 Jul 11; 57(7):1025-30. PubMed ID: 8807015
    [Abstract] [Full Text] [Related]

  • 56. [Pharmacokinetics of afobazole in rats].
    Seredenin SB, Viglinskaia AO, Kolyvanov GB, Litvin AA, Kravtsova OIu, Zherdev VP.
    Eksp Klin Farmakol; 2007 Jul 11; 70(2):59-64. PubMed ID: 17523455
    [Abstract] [Full Text] [Related]

  • 57. Pharmacokinetics and bioavailability of methylphenobarbital in man.
    Hooper WD, Kunze HE, Eadie MJ.
    Ther Drug Monit; 1981 Jul 11; 3(1):39-44. PubMed ID: 7233487
    [Abstract] [Full Text] [Related]

  • 58. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI, Chaves-Gnecco D, Amico JA, Kroboth PD, Wilson JW, Frye RF.
    Clin Pharmacol Ther; 2002 Dec 11; 72(6):718-28. PubMed ID: 12496753
    [Abstract] [Full Text] [Related]

  • 59. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 11; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 60. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
    Hughes C, Sunderji R, Gin K.
    Can J Cardiol; 1997 Sep 11; 13(9):839-42. PubMed ID: 9343033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.